- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04229056
Autoformación asistida por ordenador para mejorar la función ejecutiva (COMPEX)
Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer
Descripción general del estudio
Estado
Condiciones
Descripción detallada
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Copenhagen, Dinamarca
- Rigshospitalet
-
Copenhagen, Dinamarca
- Bispebjerg Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- A diagnose of stroke, cardiac arrest or Parkinson's disease.
- Aged 18 years or older.
- Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
- Computer and internet access at home.
- Providing informed consent.
Inclusion criteria specific for stroke
- Inclusion within 6 months post-stroke
- Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
- Initial stroke severity >/= NIHSS 3.
Inclusion criteria specific for cardiac arrest
• Inclusion within 6 months post ictus.
Inclusion criteria specific for Parkinson's disease
- Clinical diagnosis of PD.
- Anti-parkinsonian medical treatment (dopaminergic or other).
Exclusion Criteria:
- Informed consent not provided
- Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
- Not able to participate according to investigator
Exclusion criteria specific for stroke
- Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
- Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.
Exclusion criteria specific for cardiac arrest • None
Exclusion criteria specific for PD
• Diagnosis of PD Dementia according to the MDS PD Dementia criteria
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Specific computer-based cognitive rehabilitation
154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions. |
CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions. |
|
Comparador activo: General computer-based cognitive stimulation
154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities. |
For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
CABPad Working Memory Test
Periodo de tiempo: After the end of the intervention (8 weeks after baseline)
|
Test of working memory. The higher score the better (theoretically infinite score) |
After the end of the intervention (8 weeks after baseline)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
CABPad Working Memory Test - 3 months follow-up
Periodo de tiempo: At follow-up visit 3 months after end of intervention
|
Test of working memory. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after end of intervention
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making A
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making A
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making B
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making B
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
SDMT
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
SDMT
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Phonological verbal fluency test
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Phonological verbal fluency test
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Categorical verbal fluency test
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Categorical verbal fluency test
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Fear questionnaire
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
Directly after the intervention, eight weeks after inclusion
|
|
Fear questionnaire
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
At follow-up visit 3 months after the end of the intervention
|
|
mrs: Modified Rankin Scale
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
mrs: Modified Rankin Scale
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
EuroQol-5 domain (EQ-5D-5L)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner |
Directly after the intervention, eight weeks after inclusion
|
|
EuroQol-5 domain (EQ-5D-5L)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner |
At follow-up visit 3 months after the end of the intervention
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
Compliance
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Monitoring of total time spent training in minutes |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Periodo de tiempo: At follow-up visit 3 months after the end of the intervention
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
2) visual analogue scale (1-10)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more. |
Directly after the intervention, eight weeks after inclusion
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Periodo de tiempo: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
Directly after the intervention, eight weeks after inclusion
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Hanne Christensen, Professor, Bispebjerg Hospital
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Sinucleinopatías
- Trastornos cerebrovasculares
- Enfermedades Cerebrales
- Enfermedades del Sistema Nervioso Central
- Enfermedades del Sistema Nervioso
- Enfermedades Vasculares
- Enfermedades cardiovasculares
- Desordenes mentales
- Enfermedades cardíacas
- Trastornos neurocognitivos
- Trastornos cognitivos
- Enfermedades neurodegenerativas
- Trastornos del movimiento
- Trastornos Parkinsonianos
- Enfermedades de los ganglios basales
- Carrera
- Disfunción congnitiva
- Paro cardíaco
- Enfermedad de Parkinson
Otros números de identificación del estudio
- H-19039236
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
This is currently undecided
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .